Reducing Readmissions Following Radical Cystectomy: Moving Beyond Enhanced Recovery.


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
07 2020
Historique:
received: 17 08 2019
revised: 13 02 2020
accepted: 05 03 2020
pubmed: 10 4 2020
medline: 2 2 2022
entrez: 10 4 2020
Statut: ppublish

Résumé

To assess readmission outcomes of a traditional ER pathway as well as a targeted postdischarge intervention aimed at reducing hospital readmissions following RC. A prospectively maintained clinical database was used to identify patients undergoing RC before and after implementation of an ER protocol at our institution. An additional intervention aimed at reducing hospital readmission included close postdischarge follow-up and outpatient intravenous hydration (ER+). Inpatient length of stay (LOS) and readmission rates were compared between groups using Wilcoxon Rank Sum and chi-square, respectively. Univariate and multivariate logistic regression was used to identify factors associated with hospital readmission. A total of 320 patients underwent RC, including 111 and 209 patients before and after ER implementation. Median (IQR) LOS decreased from 8.0 (6.0-11.0) days to 5.0 (4.0-7.0) days following ER implementation (P <.0001). Readmissions, however, were unchanged following ER implementation (P = .49). An additional targeted readmission reduction intervention (ER+) was associated with significantly reduced hospital readmissions compared to traditional ER alone (ER+ 5.9%, traditional ER 20.3%, P = .017). ER protocols consistently demonstrate reductions in LOS, and should be the standard of care following RC. In order to reduce readmissions, the urologic community must expand beyond traditional ER pathways. We report significant reductions in hospital readmission among RC patients receiving a targeted postdischarge intervention beyond traditional ER alone.

Identifiants

pubmed: 32272122
pii: S0090-4295(20)30328-9
doi: 10.1016/j.urology.2020.03.020
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114-118

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Abhinav Khanna (A)

Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, OH. Electronic address: Khannaa3@ccf.org.

Anna Zampini (A)

Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, OH.

Alice Crane (A)

Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, OH.

Kyle Ericson (K)

Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, OH.

Prithvi Murthy (P)

Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, OH.

Michele Fascelli (M)

Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, OH.

Anna Faris (A)

Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, OH.

Georges-Pascal Haber (GP)

Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, OH.

Byron Lee (B)

Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, OH.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH